Capstone Triton Financial Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,774
Closed -$363K 108
2024
Q3
$363K Sell
5,774
-1
-0% -$58 0.23% 83
2024
Q2
$341K Hold
5,775
0.24% 81
2024
Q1
$461K Sell
5,775
-681
-11% -$52K 0.33% 76
2023
Q4
$510K Sell
6,456
-2,863
-31% -$204K 0.37% 69
2023
Q3
$651K Sell
9,319
-740
-7% -$52.4K 0.48% 62
2023
Q2
$695K Buy
10,059
+32
+0.3% +$2.28K 0.48% 65
2023
Q1
$745K Sell
10,027
-506
-5% -$42.4K 0.56% 63
2022
Q4
$982K Buy
10,533
+106
+1% +$10.2K 0.79% 47
2022
Q3
$994K Sell
10,427
-375
-3% -$37.1K 0.85% 42
2022
Q2
$1.01M Sell
10,802
-197
-2% -$19.2K 0.76% 45
2022
Q1
$1.11M Sell
10,999
-735
-6% -$77.2K 0.77% 40
2021
Q4
$1.22M Buy
11,734
+88
+0.8% +$8.13K 2.46% 3
2021
Q3
$1.02M Sell
11,646
-771
-6% -$64.6K 0.61% 41
2021
Q2
$1.04M Buy
12,417
+6,167
+99% +$505K 0.64% 45
2021
Q1
$470K Buy
6,250
+5,502
+736% +$401K 0.31% 62
2020
Q4
$51K Buy
+748
New +$48.7K 0.03% 200

Other funds holding CVS

Capstone Triton Financial Group's CVS Position: Q4 2024 in Review

Capstone Triton Financial Group sold out of CVS Health (CVS) in Q4 2024, closing a stake of 5,774 shares — an estimated $363K sold.

Capstone Triton Financial Group first reported a position in CVS in Q4 2020 and held it in 16 quarters. The position peaked at $1.22M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Capstone Triton Financial Group reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Capstone Triton Financial Group sold 5,774 CVS Health shares in Q4 2024, an estimated $363K.
  • Capstone Triton Financial Group first reported a position in CVS Health in Q4 2020 and held it in 16 quarters.
  • Capstone Triton Financial Group's CVS Health position peaked at $1.22M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Capstone Triton Financial Group's 13F filing for Q4 2024, filed 10 Mar 2025.